Viewing Study NCT02744768


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-01-04 @ 5:27 AM
Study NCT ID: NCT02744768
Status: UNKNOWN
Last Update Posted: 2018-03-22
First Post: 2016-04-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module